Brown Shipley & Co’s Abbott ABT Stock Holding History

Brown Shipley & Co’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,330	Closed	-$1.05M	–	81
2024 Q1	$1.05M	Buy	+9,330	New	+$1.07M	0.33%	37
2023 Q3	–	Sell	-8,965	Closed	-$977K	–	91
2023 Q2	$977K	Buy	+8,965	New	+$956K	0.4%	39

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Brown Shipley & Co's ABT Position: Q2 2024 in Review

Brown Shipley & Co sold out of Abbott (ABT) in Q2 2024, closing a stake of 9,330 shares — an estimated $1.05M sold.

Brown Shipley & Co first reported a position in ABT in Q2 2023 and held it in 2 quarters. The position peaked at $1.05M in Q1 2024. 2,861 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

Brown Shipley & Co reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
Brown Shipley & Co sold 9,330 Abbott shares in Q2 2024, an estimated $1.05M.
Brown Shipley & Co first reported a position in Abbott in Q2 2023 and held it in 2 quarters.
Brown Shipley & Co's Abbott position peaked at $1.05M in Q1 2024.
2,861 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Brown Shipley & Co's 13F filing for Q2 2024, filed 19 Aug 2024.